Where is the live CopyMark page for USPTO serial 78343609?

The live record is at https://getcopymark.com/trademark/78343609. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns ORPHAN MEDICAL?

According to the public USPTO record for serial number 78343609, the listed owner(s) include: Orphan Medical, Inc..

What is USPTO serial number 78343609?

Serial number 78343609 is the USPTO application identifier for the mark ORPHAN MEDICAL. It is used to track examination, publication, and registration of this trademark.

What is the current status of ORPHAN MEDICAL?

ORPHAN MEDICAL (78343609) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover ORPHAN MEDICAL?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: ORPHAN MEDICAL Serial# 78343609 | status 601; last event MAB1 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ORPHAN MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Orphan Medical, Inc.
Minnetonka, MN
Other trademarks owned by Orphan Medical, Inc.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephen R. Baird

Goods and services

Class	Description	Status	First use
005	House mark for a full line of pharmaceuticals for use in the treatment of diseases in humans and animals, namely, pharmaceutical preparations for use as an antidote to ethylene glycol and methanol poisoning, pharmaceutical preparations for use as a treatment for homocystinuria, pharmaceutical preparations for use in the treatment of the central nervous system, narcolepsy, sleep disorders, fibromyalgia, insomnia and myositis	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Feb 2, 2009	MAB1	ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT	—
Feb 2, 2009	ABN1	ABANDONMENT - EXPRESS MAILED	—
Jan 30, 2009	EXAR	TEAS EXPRESS ABANDONMENT RECEIVED	—
Sep 9, 2008	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Mar 7, 2008	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Mar 7, 2008	ALIE	ASSIGNED TO LIE	—
Sep 7, 2007	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Mar 7, 2007	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Sep 6, 2006	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Mar 1, 2006	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Aug 31, 2005	RCSC	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED	—
Feb 27, 2005	GNSL	LETTER OF SUSPENSION E-MAILED	—
Feb 27, 2005	CNSL	SUSPENSION LETTER WRITTEN	—
Feb 22, 2005	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Jan 26, 2005	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jan 26, 2005	MAIL	PAPER RECEIVED	—
Jul 24, 2004	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2004	DOCK	ASSIGNED TO EXAMINER	—
Jan 7, 2004	NWAP	NEW APPLICATION ENTERED	—

ORPHAN MEDICAL